Found 0 matching trials
Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia PHASE3 RATIONALE: Drugs used in chemotherapy, such as fludarabine, work in differe...
Show More Location
Regional Medical Center
Learn More & Join Trial
Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment PHASE2 The purpose of this study is to assess whether patients who are likely to f...
Show More Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE PHASE3 The purpose of this study is to assess whether co-administration of belimum...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma PHASE2 Monoclonal antibodies, such as yttrium Y 90 ibritumomab tiuxetan, can block...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma PHASE1 The purpose of the study is to evaluate whether recombinant IL-21 used in c...
Show More Location
University of California, Los Angeles
Learn More & Join Trial
Efficacy and Safety of Bendamustine Plus Rituximab in Chronic Lympocytic Leukemia N/A This study is intended for Chronic Lymphocytic Leukemia patients who have a...
Show More Location
Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI
Learn More & Join Trial
Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma PHASE1 This clinical trial is for men and women with whose lymphoma (non-Hodgkin o...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma PHASE1 Addition of nivolumab (immune checkpoint inhibitor) to standard chemotherap...
Show More Status
Enrolling By Invitation
Location
Dmitry Rogachev National Research Center
Learn More & Join Trial
Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma PHASE2 The purpose of this study is to determine the efficacy of SyB L-0501 in com...
Show More Location
Multiple Locations
Learn More & Join Trial
Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma PHASE2 The goal of this clinical research study is to learn if intensive chemother...
Show More Location
The University of Texas M. D. Anderson Cancer Center
Learn More & Join Trial